Verastem Oncology Announces FDA Acceptance and Priority Review of New Drug Application for Avutometinib in Combination with Defactinib for the Treatment of Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer

Published on December 30, 2024

obtain adequate financing in the future through product licensing, co-promotional arrangements, public or private equity, debt financing or

Continue reading on website
Other news

Famed investor Bill Ackman expects Trump to privatize Fannie Mae, Freddie Mac

December 30, 2024
Ackman, the billionaire founder of Pershing Square (NYSE:SQ) Capital Management, believes Trump will remove Fannie Mae and Freddie Mac

Is 3M Company (MMM) One of the Best Nanotechnology Stocks to Buy According to Hedge Funds?

December 30, 2024
trade tensions with China, which leads the world in nanotech startups, this investment is likely to grow, highlighting the strategic value